Relationship of Wnt Pathway Activity and Organ Involvement in Scleroderma Types

Loading...
Publication Logo

Date

2020

Journal Title

Journal ISSN

Volume Title

Publisher

Wiley

Open Access Color

Green Open Access

Yes

OpenAIRE Downloads

0

OpenAIRE Views

4

Publicly Funded

No
Impulse
Average
Influence
Average
Popularity
Average

Research Projects

Journal Issue

Abstract

Objective Scleroderma (SSc) is a chronic inflammatory autoimmune disease characterized by fibrosis in the skin and internal organs. In SSc, the heart, lung, kidney, gastrointestinal (GIS) system, muscle, and peri-articular structures are damaged. There is no study of the relationship between SSc type, stage, pathogenesis, organ involvement, and Wnt signaling. In this study, we aimed to show the relationship of the Wnt gene family and antagonists in SSc subtypes and different organ involvement. Methods Eighty-five SSc patients and 77 controls were included in this study. The gene expressions and protein levels of the Wnt family and antagonists were analyzed from blood samples. The relationship between these parameters and disease stage, type, and organ involvement were evaluated. Results Wnt-1, Wnt-10b, Wnt-2, and Wnt-6 gene expressions are increased and Axin-2, DKK-1, and Kremen protein expressions are decreased in SSc. Wnt-3a and Wnt-10a gene expressions are increased in generalized SSc compared to limited SSc. Wnt-1, Wnt-2 gene expressions are increased significantly in pulmonary arterial hypertension (PAH)(+) SSc compared to PAH(-) SSc. There was a positive correlation between the modified Rodnan skin score and Wnt-2 in SSc. There was a significant positive correlation between GIS involvement score and Wnt-1, Wnt-2, Wnt-4, Wnt-8a, Wnt-9b in SSc. Conclusion Wnt-1 and Wnt-2 were found higher in scleroderma and organ involvement. They may play a role in the pathogenesis of the disease.

Description

Keywords

organ involvement, scleroderma, Wnt antagonists, Wnt signaling pathway, Cutaneous Systemic-Sclerosis, Signaling Pathways, Skin Fibrosis, Beta-Catenin, Disease, Antagonists, Improvement, Inhibition, Expression, Therapy, Adult, Aged, 80 and over, Male, Middle Aged, Prognosis, Wnt Proteins, Young Adult, Scleroderma, Limited, Case-Control Studies, Scleroderma, Diffuse, Disease Progression, Humans, Female, Wnt Signaling Pathway, Aged

Fields of Science

0301 basic medicine, 03 medical and health sciences, 0302 clinical medicine

Citation

WoS Q

Q3

Scopus Q

Q3
OpenCitations Logo
OpenCitations Citation Count
3

Source

Internatıonal Journal of Rheumatıc Dıseases

Volume

23

Issue

11

Start Page

1558

End Page

1567
PlumX Metrics
Citations

CrossRef : 1

Scopus : 6

PubMed : 2

Captures

Mendeley Readers : 14

SCOPUS™ Citations

6

checked on Mar 15, 2026

Web of Science™ Citations

6

checked on Mar 15, 2026

Page Views

2

checked on Mar 15, 2026

Google Scholar Logo
Google Scholar™
OpenAlex Logo
OpenAlex FWCI
0.1439

Sustainable Development Goals

SDG data is not available